Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities
- DOI
- 10.1007/s13205-026-05098-y
- Published
- 2026-10-31
- Container
- 3 Biotech
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s13205-026-05098-y,
title = {Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities},
author = {Swaraj Kumar Babu and Sk Mustaq Ali and Dibya Ranjan Sahoo and Eeshara Naik and Reshma Pradhan and Satyanshi Behera and Surjeet Verma and Pradeep Kumar Naik},
year = {2026},
journal = {3 Biotech},
doi = {10.1007/s13205-026-05098-y},
url = {https://doi.org/10.1007/s13205-026-05098-y}
}RIS
TY - JOUR TI - Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities AU - Swaraj Kumar Babu AU - Sk Mustaq Ali AU - Dibya Ranjan Sahoo AU - Eeshara Naik AU - Reshma Pradhan AU - Satyanshi Behera AU - Surjeet Verma AU - Pradeep Kumar Naik PY - 2026 JO - 3 Biotech DO - 10.1007/s13205-026-05098-y UR - https://doi.org/10.1007/s13205-026-05098-y ER -
APA
Babu, S. K., Ali, S. M., Sahoo, D. R., Naik, E., Pradhan, R., Behera, S., Verma, S., & Naik, P. K. (2026). Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities. 3 Biotech. https://doi.org/10.1007/s13205-026-05098-y
Source records
- crossref · retrieved 2026-11-03T21:23:07.402Z